Expression of microRNAs (133b and 138) and Correlation with Echocardiographic Parameters in Patients with Alcoholic Cardiomyopathy

Author(s): Leiliandry de Araújo Melo, Maria Mariana Barros Melo da Silveira, Isabelle Cecília de Vasconcellos Piscoya, Victor Arthur Eulálio Brasileiro, Isabela Cristina Cordeiro Farias, Kleyton Palmeira do Ó, Carlos Guilhermo Piscoya Roncal, Raul Emídio Lima, Dário Celestino Sobral Filho, Luydson Richardson Silva Vasconcelos*

Journal Name: MicroRNA

Volume 9 , Issue 2 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Introduction: Alcoholic Cardiomyopathy (ACM) is a disease with a difficult diagnosis. The real mechanisms related to its pathophysiology are not fully understood.

Objective: The aims of this study were to investigate whether miR-133b and miR-138 could be associated with ACM.

Methods: Forty-four patients were included comprising 24 with ACM and 20 with cardiomyopathies of different etiologies (control group). Real-time PCR was performed to verify the relative expression among the studied groups. In the statistical analysis, the quantitative variables t-student Mann- Whitney and correlation of Pearson tests were carried out, while the qualitative variable comprised the chi-square test, with p<0.05 being considered statistically significant.

Results: There was no association between clinical and sociodemographic characteristics of the groups. The patients with ACM presented downregulation of miR-133b in comparison with control patients (p=0.004). On the other hand, for the miR-138, there was no association when the ACM group was compared with the control group. The presence of miR-133b among cases and controls was not correlated with any of the echocardiographic parameters. However, the increase in the expression of miR-138 was correlated with an increase in the ejection fraction (r=0.28, p=0.01) and the diameter of the left atrium (r=0.23, p=0.04) in patients with ACM.

Conclusion: The downregulation of miR-133b might be a marker for ACM and, in addition, miR- 138 could be used to correlate the increase in ejection fraction with and normalization of the diameter of the left atrium diameter in patients with this disease.

Keywords: Alcoholic cardiomyopathy, biomarkers, cardiomegaly, echocardiography, fibrosis, microRNA.

[1]
Steiner JL, Lang CH. Etiology of alcoholic cardiomyopathy: mitochondria, oxidative stress and apoptosis. Int J Biochem Cell Biol 2017; 89: 125-35.
[http://dx.doi.org/10.1016/j.biocel.2017.06.009] [PMID: 28606389]
[2]
Pfeiffer D, Jurisch D, Neef M, Hagendorff A. Alkohol und Rhythmusstörungen. Herz 2016; 41(6): 498-502.
[http://dx.doi.org/10.1007/s00059-016-4463-z] [PMID: 27582366]
[3]
Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol 2014; 14(4): 291-308.
[http://dx.doi.org/10.1007/s12012-014-9252-4] [PMID: 24671642]
[4]
Iacovoni A, De Maria R, Gavazzi A. Alcoholic cardiomyopathy. J Cardiovasc Med (Hagerstown) 2010; 11(12): 884-92.
[http://dx.doi.org/10.2459/JCM.0b013e32833833a3] [PMID: 20308914]
[5]
Walker RK, Cousins VM, Umoh NA, et al. The good, the bad, and the ugly with alcohol use and abuse on the heart. Alcohol Clin Exp Res 2013; 37(8): 1253-60.
[http://dx.doi.org/10.1111/acer.12109] [PMID: 23527963]
[6]
Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol 2014; 6(8): 771-81.
[http://dx.doi.org/10.4330/wjc.v6.i8.771] [PMID: 25228956]
[7]
Li M, Zhang J. Circulating microRNAs: potential and emerging biomarkers for diagnosis of cardiovascular and cerebrovascular diseases. BioMed Res Int 2015; 2015 730535
[PMID: 26180810]
[8]
Xu J, Zhao J, Evan G, Xiao C, Cheng Y, Xiao J. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med (Berl) 2012; 90(8): 865-75.
[http://dx.doi.org/10.1007/s00109-011-0840-5] [PMID: 22159451]
[9]
Pietrzykowski AZ, Friesen RM, Martin GE, et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008; 59(2): 274-87.
[http://dx.doi.org/10.1016/j.neuron.2008.05.032] [PMID: 18667155]
[10]
Guo R, Hu N, Kandadi MR, Ren J. Facilitated ethanol metabolism promotes cardiomyocyte contractile dysfunction through autophagy in murine hearts. Autophagy 2012; 8(4): 593-608.
[http://dx.doi.org/10.4161/auto.18997] [PMID: 22441020]
[11]
Jing L, Jin C, Lu Y, et al. Investigation of microRNA expression profiles associated with human alcoholic cardiomyopathy. Cardiology 2015; 130(4): 223-33.
[http://dx.doi.org/10.1159/000370028] [PMID: 25791397]
[12]
Wang Z, Song J, Zhang L, et al. Increased expression of microRNA-378a-5p in acute ethanol exposure of rat cardiomyocytes. Cell Stress Chaperones 2017; 22(2): 245-52.
[http://dx.doi.org/10.1007/s12192-016-0760-y] [PMID: 28160209]
[13]
Rubiś AP, Totoń-żurańska J, Wiśniowska-śmiałek S, et al. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy. Cardiol J 2018; 25(6): 722-31.
[PMID: 28840590]
[14]
Zhang X, Li SY, Brown RA, Ren J. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol 2004; 32(3): 175-86.
[http://dx.doi.org/10.1016/j.alcohol.2004.01.005] [PMID: 15282111]
[15]
Boscher E, Husson T, Quenez O, et al. Copy number variants in mir-138 as a potential risk factor for early-onset Alzheimer’s disease. J Alzheimers Dis 2019; 68(3): 1243-55.
[http://dx.doi.org/10.3233/JAD-180940] [PMID: 30909216]
[16]
Tan Y, Hu H, Tan W, Jin L, Liu J, Zhou H. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1. Mol Med Rep 2016; 14(5): 4422-8.
[http://dx.doi.org/10.3892/mmr.2016.5769] [PMID: 27665963]
[17]
Tanaka K, Kawano M, Itonaga I, et al. Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing’s sarcoma cells. Int J Oncol 2016; 48(3): 1135-44.
[http://dx.doi.org/10.3892/ijo.2016.3317] [PMID: 26782922]
[18]
Golubovskaya VM, Sumbler B, Ho B, Yemma M, Cance WG. MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells. Anticancer Agents Med Chem 2014; 14(1): 18-28.
[http://dx.doi.org/10.2174/187152061401140108113435] [PMID: 23438844]
[19]
Yu Z, Wang Z, Li F, Yang J, Tang L. miR-138 modulates prostate cancer cell invasion and migration via Wnt/β-catenin pathway. Mol Med Rep 2018; 17(2): 3140-5.
[PMID: 29257301]
[20]
Wang Y, Zhang H, Ge S, et al. Effects of miR-138-5p and miR-204-5p on the migration and proliferation of gastric cancer cells by targeting EGFR. Oncol Rep 2018; 39(6): 2624-34.
[http://dx.doi.org/10.3892/or.2018.6389] [PMID: 29693184]
[21]
Vacchi-Suzzi C, Hahne F, Scheubel P, et al. Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions. PLoS One 2013; 8(1) e52442
[http://dx.doi.org/10.1371/journal.pone.0052442] [PMID: 23300973]
[22]
Li B, Ding CM, Li YX, Peng JC, Geng N, Qin WW. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR. Oncol Rep 2018; 39(3): 1227-34.
[http://dx.doi.org/10.3892/or.2018.6215] [PMID: 29344640]
[23]
Wang X, Zeng J, Wang L, et al. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: involvement of the EGFR/PI3K/Akt/mTOR signaling pathway. Oncol Rep 2017; 38(1): 141-50.
[http://dx.doi.org/10.3892/or.2017.5699] [PMID: 28586051]
[24]
Yao J, Wang J, Yao Y, Wang K, Zhou Q, Tang Y. miR-133b regulates proliferation and apoptosis in high-glucose-induced human retinal endothelial cells by targeting ras homolog family member A. Int J Mol Med 2018; 42(2): 839-50.
[PMID: 29786744]
[25]
Katano H, Nishikawa Y, Yamada H, Yamada K, Mase M. Differential expression of microRNAs in severely calcified carotid plaques. J Stroke Cerebrovasc Dis 2018; 27(1): 108-17.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.009] [PMID: 28939047]
[26]
Zhang X, Schulze PC, Dyck JRB, Glatz JFC. MicroRNAs in heart failure: non-coding regulators of metabolic function. Biochim Biophys Acta 2016; 1862(12): 2276-87.
[http://dx.doi.org/10.1016/j.bbadis.2016.08.009] [PMID: 27544699]
[27]
Ferreira LRP, Frade AF, Santos RHB, et al. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic Chagas disease cardiomyopathy. Int J Cardiol 2014; 175(3): 409-17.
[http://dx.doi.org/10.1016/j.ijcard.2014.05.019] [PMID: 24910366]
[28]
Boštjančič E, Jerše M, Glavač D, Zidar N. miR-1, miR-133a/b, and miR-208a in human fetal hearts correlate to the apoptotic and proliferation markers. Exp Biol Med (Maywood) 2015; 240(2): 211-9.
[http://dx.doi.org/10.1177/1535370214546268] [PMID: 25125495]
[29]
Calvano J, Achanzar W, Murphy B, et al. Evaluation of microRNAs-208 and 133a/b as differential biomarkers of acute cardiac and skeletal muscle toxicity in rats. Toxicol Appl Pharmacol 2016; 312: 53-60.
[http://dx.doi.org/10.1016/j.taap.2015.11.015] [PMID: 26627004]
[30]
Wang Y, Li M, Xu L, et al. Expression of Bcl-2 and microRNAs in cardiac tissues of patients with dilated cardiomyopathy. Mol Med Rep 2017; 15(1): 359-65.
[http://dx.doi.org/10.3892/mmr.2016.5977] [PMID: 27922664]
[31]
Shan H, Zhang Y, Lu Y, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83(3): 465-72.
[http://dx.doi.org/10.1093/cvr/cvp130] [PMID: 19398468]
[32]
Elzenaar I, Pinto YM, van Oort RJ. MicroRNAs in heart failure: new targets in disease management. Clin Pharmacol Ther 2013; 94(4): 480-9.
[http://dx.doi.org/10.1038/clpt.2013.138] [PMID: 23852395]
[33]
Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 2010; 225(3): 631-7.
[http://dx.doi.org/10.1002/jcp.22322] [PMID: 20635395]
[34]
Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104(2): 170-178, 6p, 178.
[http://dx.doi.org/10.1161/CIRCRESAHA.108.182535] [PMID: 19096030]
[35]
Zhu Z, Huang Y, Lv L, et al. Acute ethanol exposure-induced autophagy-mediated cardiac injury via activation of the ROS-JNK-Bcl-2 pathway. J Cell Physiol 2018; 233(2): 924-35.
[http://dx.doi.org/10.1002/jcp.25934] [PMID: 28369910]
[36]
He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2013; 62(4): 1270-81.
[http://dx.doi.org/10.2337/db12-0533] [PMID: 23223177]
[37]
Li S, Ran Y, Zhang D, Chen J, Li S, Zhu D. MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. Biochem J 2013; 452(2): 281-91.
[http://dx.doi.org/10.1042/BJ20120680] [PMID: 23485012]
[38]
Xiong H, Luo T, He W, et al. Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression. Exp Biol Med (Maywood) 2016; 241(1): 25-30.
[http://dx.doi.org/10.1177/1535370215591831] [PMID: 26129883]
[39]
He S, Liu P, Jian Z, et al. miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun 2013; 441(4): 763-9.
[http://dx.doi.org/10.1016/j.bbrc.2013.10.151] [PMID: 24211202]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 2
Year: 2020
Page: [112 - 120]
Pages: 9
DOI: 10.2174/2211536608666190716151900

Article Metrics

PDF: 21
HTML: 3